Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Guardian Financial Partners LLC

Guardian Financial Partners LLC boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,466 shares of the medical equipment provider’s stock after buying an additional 26 shares during the quarter. Guardian Financial Partners LLC’s holdings in Intuitive Surgical were worth $765,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of ISRG. Massachusetts Financial Services Co. MA purchased a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $558,807,000. International Assets Investment Management LLC lifted its position in shares of Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after acquiring an additional 1,088,415 shares in the last quarter. FMR LLC increased its position in shares of Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Wilmington Savings Fund Society FSB boosted its stake in Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after purchasing an additional 552,058 shares during the last quarter. Finally, State Street Corp raised its position in shares of Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after buying an additional 210,363 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of analyst reports. Wells Fargo & Company upped their price target on Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, December 11th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. BTIG Research upped their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Finally, Robert W. Baird raised their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $554.17.

Intuitive Surgical Stock Up 0.3 %

Shares of NASDAQ:ISRG opened at $582.01 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $355.17 and a fifty-two week high of $584.60. The company has a market cap of $207.30 billion, a price-to-earnings ratio of 93.57, a PEG ratio of 4.66 and a beta of 1.39. The firm’s 50-day simple moving average is $537.05 and its 200-day simple moving average is $496.50.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. On average, research analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Transactions at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 2,553 shares of the business’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the sale, the executive vice president now directly owns 7,066 shares in the company, valued at $3,638,990. The trade was a 26.54 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Mark Brosius sold 2,128 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the transaction, the senior vice president now owns 273 shares of the company’s stock, valued at $140,595. This trade represents a 88.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock valued at $25,012,927 in the last quarter. 0.80% of the stock is currently owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.